Transition of newly received feedlot cattle from a forage- to grain-based diet is challenging, and the appropriate roughage level in receiving diets is debatable. Nutritionists must consider the ...paradox of dietary transition and roughage level to mitigate ruminal acidosis, yet concomitantly low feed intake presents difficulty in achieving nutrient requirements when metabolic demand is increased due to inherent stress and disease challenge during the receiving period. Previous research suggests that performance is improved at the expense of increased morbidity for newly received cattle consuming diets with less roughage and greater starch concentration. The clinical signs of bovine respiratory disease (BRD) and acute acidosis are analogous; therefore, it is probable that acidotic cattle are incorrectly diagnosed with BRD in both research and production settings. Additional research efforts have attempted to elucidate alterations in microbial populations and digestion, physiological response to inflammatory challenge, and immunological response to infectious bovine rhinotracheitis virus challenge in cattle consuming diets of various roughage levels. Furthermore, our understanding of the rumen microbiome is improving rapidly with culture-independent assays, products such as direct-fed microbials are available, and increased availability and use of fibrous byproduct ingredients requires further attention. Beef cattle nutritionists and producers should consider that the health benefit of receiving diets containing greater levels of roughage and lower energy may not compensate for the reduction in performance compared with feeding receiving diets with lower roughage and greater energy.
Abstract
Auction-derived steers (n = 36; initial BW = 284 ± 11 kg) were received to compare performance, rumination characteristics, and rumen pH differences due to alternative ration energy ...densities and feed management strategies during a 56 d receiving study. Cattle were weighed on day -1 and randomized to 1 of 3 treatments. Time spent ruminating was quantified with a three-axis accelerometer ear-tag. Rumen pH and temperature were logged in a random subset (n = 6 per treatment) by a ruminal bolus. Cattle were processed identically and housed in individual pens. The modified-live virus respiratory vaccination was delayed until day 28. The finisher (FIN) cattle were provided their daily feed as a high energy density (1.39 Mcal NEg/kg) diet. The finisher + hay (FIN+H) cattle were provided the same diet but were also offered 0.5% BW DM as coastal Bermudagrass hay on days 1, 4, 7, 10, 13, 16, 19, 22, 25, and 28. The control (CON) cattle were fed a low energy density (0.93 Mcal NEg/kg) diet from day 0 to 7, then transitioned to the FIN diet by replacing an additional 25% of the daily feed call with FIN every 7 d until 100% of the diet was FIN on day 29. Feed offering for CON was increased more aggressively (0.45 kg DM daily for days 1 to 7, every other day for day 8 to 14) than FIN and FIN+H (0.45 kg DM every other day for days 1 to 7, daily for days 8 to 14). Performance and DMI were analyzed using PROC MIXED in SAS with treatment as a fixed effect. Rumination, pH, and temperature models included repeated measures. There was no treatment difference observed for BW, average daily gain (ADG), or G:F (P ≥ 0.12). There was a treatment × day interaction (P = 0.06) for rumen temperature, where FIN increased more rapidly following vaccination on day 28 compared to CON (P ≤ 0.04). Daily rumination minutes were greater (P < 0.01) for CON than FIN from days 7 to 22. Additionally, CON had the greatest (P < 0.01) hourly rumination from 2000 to 0800 hours. Lower minimum daily rumen pH occurred in FIN+H (P ≤ 0.06) on weeks 1, 2 and 6 to 8 compared to CON. There were minimal statistical differences in area under the curve or time below pH thresholds, probably due to large animal-to-animal variation. Hourly rumen pH was reduced (P ≤ 0.05) for FIN vs. FIN+H and CON during the initial 28 d, but greater (P = 0.05) for FIN and FIN+H during the final 28 d. When cattle are individually fed, greater energy density rations can be fed initially without compromising performance, but this needs to be evaluated in group pens where greater DMI variation is probable.
Abstract
The study objectives were to determine the effect of oral hydration therapy and bovine respiratory disease (BRD) on rumination behavior, rumen pH, and rumen temperature. A random subset of ...high-risk, auction-sourced bulls from 3 truckload blocks (initial BW = 188.9 ± 19.1 kg) were fitted with a collar containing a 3-axis accelerometer to quantify rumination time and activity (n = 58) and administered a rumen pH and temperature data logging bolus (n = 33). At arrival, subset calves (n = 2 per pen) were balanced across treatment pens (n = 15 per treatment; n = 10 animals per pen) and randomized to receive 0.57 L water/45.4 kg BW from a modified oral drenching apparatus (H2O) or no water administration (CON). Standard arrival processing procedures were implemented including surgical castration. Modified-live virus respiratory vaccination was delayed until day 28. Technicians assigned a clinical illness score (CIS) daily; calves with CIS ≥ 2 and rectal temperature ≥ 40 °C were considered a BRD case (RCASE) and treated with an antimicrobial. The fixed effect of BRD cases vs. nontreated cohorts (RCON) was determined retrospectively using data from the accelerometer collar (n = 19 and 29) and rumen bolus (n = 12 and 21, for RCASE and RCON, respectively). Daily means and hourly means across days throughout the 56-d observation period were generated. Fixed effects were analyzed using the mixed model procedure with repeated measures. Daily rumen temperature was altered (P = 0.04) such that peak rumen temperature occurred earlier for H2O, whereas CON had increased (P ≤ 0.01) rumen temperature following delayed vaccination on day 28. Calves diagnosed with BRD had a transiently decreased (P = 0.04) active minutes between days 9 and 32, decreased (P < 0.01) active minutes between 0800 and 2000 h, decreased (P < 0.01) rumination time between 2000 and 0400 h, greater (P < 0.01) rumen temperature until delayed vaccination on day 28, and greater (P < 0.01) hourly rumen temperature between 0900 and 0300, and altered (P < 0.01) rumen pH. Earlier peak rumen temperature observed in H2O may indicate physiological modification enabling a more pronounced inflammatory response. Differences in rumination behavior and activity may be useful for early BRD detection.
The study objective was to determine if a combined weaning and transportation stress model affected performance, antibody, endocrine, or hematological responses to modified-live virus (MLV) or killed ...virus (KV) respiratory vaccination in beef steers. In total, 48 calves (Day 0 BW = 226 ± 6.2 kg) from a single origin were used in a 2 × 2 factorial to evaluate main effects of stress model, vaccine type, and their interaction, resulting in four treatments (n = 12/treatment) including non-stress control (C) with KV (CKV), C with MLV (CMLV), stress model implementation (S) with KV (SKV), and S with MLV (SMLV). The C calves were weaned at the origin ranch on Day −37 and transported 472 km to the study site on Day −21 to allow acclimation. The S calves were weaned on Day −3, transported 460 km to a research facility on Day −2, held overnight, and transported 164 km to the study site on Day −1 to mimic the beef cattle marketing process. Vaccines were administered on Day 0 and KV was revaccinated on Day 14. The animal was the experimental unit and dependent variables were analyzed using PROC MIXED with repeated measures (day). A stress model effect (p = 0.01) existed for DMI from Day 0 to Day 7 with greater DMI for C (6.19 vs. 4.64 kg/day) when compared to S. The MLV groups had reduced (p = 0.05) ADG from Day 0 to Day 56, compared to KV. There was a vaccine type × day (p < 0.01) interaction with increased (p ≤ 0.01) PI3V- and IBRV-specific antibody titers for KV on Day 21; conversely, MLV had increased (p ≤ 0.01) BVDV titers on Days 14, 28, 35, 42, 49, and 56. Increased (p ≤ 0.05) BRSV titers were observed in a stress model × day (p < 0.01) interaction for S on Days 21, 28, 36, and 42; however, C exceeded S in BVDV-specific antibody concentration on Days 21, 28, and 49. A day effect (p < 0.01) was observed for serum haptoglobin with the greatest (p < 0.01) concentration on Day 3. Serum cortisol concentration was greater (p ≤ 0.04) for C vs. S on Days −2, 0, 1, 3, and 5. Total leukocytes were decreased for C vs. S on Days 0, 1, 3, 5, 7, 14, and 21 (p ≤ 0.02). A reduction (p ≤ 0.04) in total leukocytes was observed for MLV on Days 5, 7, and 14 vs. KV. Neutrophils and neutrophil:lymphocyte were markedly increased (p ≤ 0.01) for S on Day −2, whereas neutrophils were decreased (p ≤ 0.01) on Days 1 and 21 for S. Monocytes were decreased on Days 1, 5 and 7 for MLV (p ≤ 0.04) and Days −2 to 14 for S (p ≤ 0.03). Eosinophils were reduced (p = 0.007) for S vs. C on Day −2, yet a distinct rebound response (p = 0.03) was noted for S on Day 0. The results indicate that S and MLV vaccination more profoundly induced immunomodulation in beef calves.
Abstract
Transition of newly received feedlot cattle from a forage- to grain-based diet is challenging, and the appropriate roughage level in receiving diets is debatable. Nutritionists must consider ...the paradox of dietary transition and roughage level to mitigate ruminal acidosis, yet concomitantly low feed intake presents difficulty in achieving nutrient requirements when metabolic demand is increased due to inherent stress and disease challenge during the receiving period. Previous research suggests that performance is improved at the expense of increased morbidity for newly received cattle consuming diets with less roughage and greater starch concentration. The clinical signs of bovine respiratory disease (BRD) and acute acidosis are analogous; therefore, it is probable that acidotic cattle are incorrectly diagnosed with BRD in both research and production settings. Additional research efforts have attempted to elucidate alterations in microbial populations and digestion, physiological response to inflammatory challenge, and immunological response to infectious bovine rhinotracheitis virus challenge in cattle consuming diets of various roughage levels. Furthermore, our understanding of the rumen microbiome is improving rapidly with culture-independent assays, products such as direct-fed microbials are available, and increased availability and use of fibrous byproduct ingredients requires further attention. Beef cattle nutritionists and producers should consider that the health benefit of receiving diets containing greater levels of roughage and lower energy may not compensate for the reduction in performance compared with feeding receiving diets with lower roughage and greater energy.
Abstract
Three monensin levels during a stocker phase (0, 800, 1600 g/ton fed in a free choice mineral) and two levels during finishing 0 (U) or 37.5 mg/kg diet DM (M) were used to determine the ...effects of monensin supplementation during a stocker and subsequent finishing phase on rumen bacterial communities of beef steers. Thirty calves were fed pearl millet (Pennisetum glaucum) hay with soybean hull and corn gluten feed supplement (0.5% BW daily, AF basis) or grazed fall wheat pasture (Triticum aestivum) during a stocker phase and then transported 1,067 km to Canyon, TX, for finishing. Rumen fluid was collected on d 0, 28, and the end of the stocker phase (d 85). Samples were also obtained at feedlot d 0, 14, 28, 56, and immediately prior to a diet change to include a beta-adrenergic agonist and before shipping for harvest. Rumen microbiota were characterized by next generation sequencing the 16S v4 hypervariable region with the Illumina MiSeq platform. During the stocker phase, Prevotella and Bacteroidetes were the most dominant genus regardless of diet or treatment. Monensin decreased (P ≤ 0.01) alpha diversity (Shannon Index) for cattle consuming hay on d 28 of the stocker phase. In the feedlot, Prevotella, Lachnospiraceae, and Bacteroidetes were the most abundant genus. Steers that were previously on the 0 and 1600 treatments during the stocker phase and were fed monensin at the feedlot had decreased alpha diversity (P = 0.04) on feedlot d 14 compared to those that did not. Monensin at the feedlot tended to increase alpha diversity on d 28 for cattle previously on the 1600 treatment (P = 0.06), and on d 56 for cattle previously on the 0 treatment (P = 0.06). This experiment provides a better understanding of the effect of monensin on rumen bacterial communities throughout production.
Abstract
The study objective was to explore the feasibility of an alternative injection site, ischiorectal fossa (IRF), for modified-live virus (MLV) vaccination in Jersey steers. We hypothesized ...administration of MLV in the IRF would not cause injection site lesions and result in similar antibody response against bovine viral diarrhea virus (BVDV) compared to the neck. Jersey steers (n = 28; BW=517 ± 116 kg) were stratified by a previously assigned growth implant treatment and day-35 BVDV antibody titer and randomly assigned to 1 of 2 treatments with injection treatment equivalently represented in each of 2 pens. Treatments consisted of: 1) 2 mL MLV vaccine administered s.c. in the neck (NECK); or 2) 2 mL MLV vaccine administered s.c. in the IRF. Blood was collected on days -35, 0, 35, 70, and 105 to determine BVDV-specific antibody titers using the virus neutralization assay and BW was recorded on the same days to determine gain performance. Steers were harvested on day 106 and examined for lesions respective to injection site. Antibody titers and performance variables were statistically analyzed via a mixed model with animal as the experimental unit. Concentration of BVDV antibody increased (P = 0.05) with time, but there was no treatment difference (P = 0.94) or treatment × day interaction (P = 0.70). There was no treatment difference for BW on any day (P ≥ 0.78). There was also no treatment difference in ADG (P ≥ 0.45). However, there was a period effect, where ADG was reduced markedly (P < 0.0001) for the day 0 to 35 interim period immediately following MLV vaccination compared to day -35 to 0 (0.79 vs. 0.18 kg/d). No injection site lesions were observed during harvest and results from BVDV antibody titers and performance indicate IRF as a potential alternative route of administration for MLV vaccines.
The study objective was to explore the feasibility of an alternative injection site, ischiorectal fossa (IRF), for modified-live virus (MLV) vaccination in Jersey steers. We hypothesized ...administration of MLV in the IRF would not cause injection site lesions and result in similar antibody response against bovine viral diarrhea virus (BVDV) compared to the neck. Jersey steers (n = 28; BW=517 ± 116 kg) were stratified by a previously assigned growth implant treatment and day-35 BVDV antibody titer and randomly assigned to 1 of 2 treatments with injection treatment equivalently represented in each of 2 pens. Treatments consisted of: 1) 2 mL MLV vaccine administered s.c. in the neck (NECK); or 2) 2 mL MLV vaccine administered s.c. in the IRF. Blood was collected on days -35, 0, 35, 70, and 105 to determine BVDV-specific antibody titers using the virus neutralization assay and BW was recorded on the same days to determine gain performance. Steers were harvested on day 106 and examined for lesions respective to injection site. Antibody titers and performance variables were statistically analyzed via a mixed model with animal as the experimental unit. Concentration of BVDV antibody increased (P = 0.05) with time, but there was no treatment difference (P = 0.94) or treatment × day interaction (P = 0.70). There was no treatment difference for BW on any day (P ≥ 0.78). There was also no treatment difference in ADG (P ≥ 0.45). However, there was a period effect, where ADG was reduced markedly (P < 0.0001) for the day 0 to 35 interim period immediately following MLV vaccination compared to day -35 to 0 (0.79 vs. 0.18 kg/d). No injection site lesions were observed during harvest and results from BVDV antibody titers and performance indicate IRF as a potential alternative route of administration for MLV vaccines.
Abstract
The study objective was to determine the effect of a DNA immunostimulant on recrudescence of bovine herpesvirus-1 (BHV-1) after dexamethasone challenge in beef cattle. It was hypothesized ...that the DNA immunostimulant would mitigate stress-induced immunosuppression; thereby, reducing the incidence of BHV-1 recrudescence. Steers (n = 10) and heifers (n = 10; initial BW = 489 kg ± 57 kg) were stratified by pre-existing BHV-1 antibody titer, sex and initial BW and randomly assigned to treatment (n = 4 pens/treatment; 2 or 3 animals/pen). All calves were administered 40 mg of dexamethasone i.v. at 0600 h from d 0 to 2, 166-d subsequent to BHV-1 challenge with 1.0 × 108 plaque-forming units per nostril. On d 1, calves were administered treatments consisting of 2 mL i.m. of DNA immunostimulant (Zelnate; ZEL) or sterile saline (CON). Once daily (0600) from d 0 to 12, a whole blood was obtained via jugular venipuncture for complete blood count (CBC) analysis and nasal swabs were collected to determine BHV-1 prevalence via virus isolation testing. A repeated measures mixed model was used to test the effect of treatment, day and their interaction for CBC variables. There was a treatment × day interaction for eosinophils (P = 0.02) and percent eosinophils (P = 0.03). Eosinophils were greater (P < 0.01) for ZEL on d 3 and 6 post-dexamethasone challenge. On d 11 and 12, eosinophils for CON rebounded such that their concentration was greater than ZEL (P < 0.01). Lymphocytes, neutrophil and monocyte concentration did not differ (P ≥ 0.44); however, a day effect (P ≤ 0.01) existed such that each variable increased transiently after dexamethasone challenge. All cattle had BHV-1 present in a nasal swab sample on at least one sample day, with prevalence of BHV-1 in nasal swab samples being greatest on d 5 (80% positive; P = 0.01). However, no treatment differences were detected for BHV-1 prevalence in this study. The DNA immunostimulant altered eosinophil concentrations but did not mitigate BHV-1 recrudesce after dexamethasone challenge
Abstract
The study objective was to determine the effect of a DNA immunostimulant on recrudescence of bovine herpesvirus-1 (BHV-1) after dexamethasone challenge in beef cattle. It was hypothesized ...that the DNA immunostimulant would mitigate stress-induced immunosuppression; thereby, reducing the incidence of BHV-1 recrudescence. Steers (n=10) and heifers (n=10; initial BW = 489 kg ± 57 kg) were stratified by pre-existing BHV-1 antibody titer, sex and initial BW and randomly assigned to treatment (n=4 pens/treatment; 2 or 3 animals/pen). All calves were administered 40 mg of dexamethasone i.v. at 0600 h from d 0 to 2, 166-d subsequent to BHV-1 challenge with 1.0 × 108 plaque-forming units per nostril. On d 1, calves were administered treatments consisting of 2 mL i.m. of DNA immunostimulant (Zelnate; ZEL) or sterile saline (CON). Once daily (0600) from d 0 to 12, a whole blood was obtained via jugular venipuncture for complete blood count (CBC) analysis and nasal swabs were collected to determine BHV-1 prevalence via virus isolation testing. A repeated measures mixed model was used to test the effect of treatment, day and their interaction for CBC variables. There was a treatment × day interaction for eosinophils (P = 0.02) and percent eosinophils (P = 0.03). Eosinophils were greater (P < 0.01) for ZEL on d 3 and 6 post-dexamethasone challenge. On d 11 and 12, eosinophils for CON rebounded such that their concentration was greater than ZEL (P < 0.01). Lymphocytes, neutrophil and monocyte concentration did not differ (P ≥ 0.44); however, a day effect (P ≤ 0.01) existed such that each variable increased transiently after dexamethasone challenge. All cattle had BHV-1 present in a nasal swab sample on at least one sample day, with prevalence of BHV-1 in nasal swab samples being greatest on d 5 (80% positive; P = 0.01). However, no treatment differences were detected for BHV-1 prevalence in this study. The DNA immunostimulant altered eosinophil concentrations but did not mitigate BHV-1 recrudesce after dexamethasone challenge
PDF
